Change Healthcare Inc. (CHNG) — Financial statements
Income statement, balance sheet, and cash flow for Change Healthcare Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 3,481↑12.6% | 3,090↑1470.4% | 197 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00↓100.0% | 1,532↑1721.9% | 84 | 0.00 | 0.00 | |
| Gross Profit | 3,481↑123.3% | 1,559↑1282.8% | 113 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 278↑22.4% | 227↑1864.1% | 12 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00↓100.0% | 1↑543.9% | 0.18 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 40 | 0.00 | 0.00 | |
| SG&A Expenses | 735↑7.0% | 687↑1621.2% | 40↑3342.0% | 1↑543.9% | 0.18 | |
| Other Expenses | 2,332↑82.5% | 1,278↑553.6% | 195↑8532.7% | -2↓543.9% | -0.36 | |
| Operating Expenses | 3,344↑11.8% | 2,990↑1111.0% | 247↑21404.8% | -1↓543.9% | -0.18 | |
| Total Costs & Expenses | 3,344↑10.1% | 3,036↑817.4% | 331↑28458.2% | 1↑543.9% | 0.18 | |
| Operating Results | ||||||
| Operating Income | 225↑125.3% | 100↑114.1% | -711↓61261.9% | -1↓543.9% | -0.18 | |
| Depreciation & Amortization | 682↑15.1% | 592↑729.2% | 71↑202.9% | -69↓18.7% | -58 | |
| EBITDA | 810↑17.4% | 690↑168.8% | -1,003↓1320.2% | -71↓20.4% | -59 | |
| EBIT | 128↑31.1% | 98↑109.1% | -1,074↓92583.3% | -1↓543.9% | -0.18 | |
| Interest & Other Income | ||||||
| Net Interest Income | -234↑4.5% | -245↓1372.7% | -17 | 0.00 | 0.00 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 234↓4.5% | 245↑1372.7% | 17 | 0.00 | 0.00 | |
| Non-Operating Income | 97↑4267.6% | 2↓99.4% | 363 | 0.00 | 0.00 | |
| Other Income / Expenses | -331↓33.9% | -247↑34.8% | -380↓446.7% | -69↓18.7% | -58 | |
| Income Before Tax | -106↑28.1% | -147↑86.5% | -1,091↓1445.0% | -71↓20.4% | -59 | |
| Income Tax Expense | 49↑238.2% | -35↑75.4% | -143↓670.4% | -19↑84.5% | -120 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -155↓37.8% | -112↑88.2% | -948↓1721.9% | -52↓185.3% | 61 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -155↓37.8% | -112↑88.2% | -948↓1721.9% | -52↓185.3% | 61 | |
| Bottom-Line Net Income | -155↓37.8% | -112↑88.2% | -948↓1721.9% | -52↓185.3% | 61 | |
| EPS (Basic) | -0.48↓37.1% | -0.35↑94.9% | -6.92↓1472.7% | -0.44↓184.6% | 0.52 | |
| EPS (Diluted) | -0.48↓37.1% | -0.35↑94.9% | -6.92↓1472.7% | -0.44↓184.6% | 0.52 | |
| Weighted Average Shares | 324↑1.0% | 321↑134.1% | 137↑15.8% | 118↑0.0% | 118 | |
| Weighted Average Diluted Shares | 324↑1.0% | 321↑134.1% | 137↑15.8% | 118↑0.0% | 118 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.